Please login to the form below

Not currently logged in
Email:
Password:

diversity

This page shows the latest diversity news and features for those working in and with pharma, biotech and healthcare.

Janet Woodcock named acting commissioner of the FDA

Janet Woodcock named acting commissioner of the FDA

I also plan to support and promote our commitment to diversity and inclusion, that is such a strength within the agency,” she added.

Latest news

More from news
Approximately 3 fully matching, plus 134 partially matching documents found.

Latest Intelligence

  • 2021: the year of decentralisation in drug development 2021: the year of decentralisation in drug development

    Improve patient-centricity, trial quality and outcomes with digital health. COVID-19 highlighted the lack of diversity in clinical research, as certain segments of the population, such as older adults, pregnant ... As a result, recently published FDA

  • Is creativity in quarantine? Is creativity in quarantine?

    That requires cross-pollination across businesses and brands; mobilising skilled, collaborative and multi-faceted teams that bring diversity and difference to thinking – and lining everything up with customer needs to develop ... Creativity cannot

  • Leadership and talent Leadership and talent

    Is a focus on a distinct employee population, in the hope of increasing the diversity of senior talent, the right thing to be investing in right now? ... Increased engagement leads to better performance, both individual and collective. It also provides

  • Switzerland: a life sciences hub Switzerland: a life sciences hub

    Switzerland has a rich diversity of pharma and biotech companies that sustain activity and help maintain its reputation as a highly innovative country. ... diversity of pharma and biotech companies that sustain activity and help Switzerland maintain its

  • Could formulary intelligence be your brand differentiator?

    If you fail to understand – and plan for – the complexity and diversity of the formulary landscape, you will inevitably fall short of commercial expectations in the crucial first year of launch.

More from intelligence
Approximately 2 fully matching, plus 53 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 14 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 26 fully matching, plus 42 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Healthcare Media Europe – HME Ltd

HME are an innovative and technology enabled agency offering our clients over 35+ years of knowledge and expertise in delivering...

Latest intelligence

EU health fund
An EU emergency health fund to limit the impact of future crises
Leading finance experts propose an Emergency Health Financing Facility to limit the impact of future crises on the EU...
Mistrust in medical research: a patient perspective
The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the...
Real-world evidence: breaking boundaries in rare disease
Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and...

Infographics